Patients with locally advanced T4 high risk prostate cancer research hub

A feasibility trial investigating inductive Apalutamide therapy combined with radical prostatectomy in patients with locally advanced T4 high risk prostate cancer

This study looks at a new drug, JNJ-56021927, for men with aggressive prostate cancer that hasn't spread. It aims to see if treating with this drug before surgery can help shrink the cancer and make surgery more successful, measuring how many men become able to have their prostate removed.